Skip to main content
Erschienen in: Pediatric Cardiology 8/2017

04.09.2017 | Original Article

Electrocardiographic Markers of Appropriate Implantable Cardioverter-Defibrillator Therapy in Young People with Congenital Heart Diseases

verfasst von: Dunia Bárbara Benítez Ramos, Michel Cabrera Ortega, Jesús Castro Hevia, Margarita Dorantes Sánchez, Ailema Amelia Alemán Fernández, Osmin Castañeda Chirino, Marlenis Cruz Cardentey, Frank Martínez López, Roylan Falcón Rodríguez

Erschienen in: Pediatric Cardiology | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

Implantable cardioverter-defibrillators (ICDs) are increasingly utilized in patients with congenital heart disease (CHD). Prediction of the occurrence of shocks is important if improved patient selection is desired. The electrocardiogram (ECG) has been the first-line tool predicting the risk of sudden death, but data in CHD patients are lacking. We aim to evaluate the predictive value of electrocardiographic markers of appropriate therapy of ICD in young people with CHD. We conducted a prospective, longitudinal study, in twenty-six CHD patients (mean age 24.7 ± 5.3 years) who underwent first ICD implantation. Forty-two age- and diagnosis-matched controls were recruited. Twelve-lead ECG and 24 h Holter analysis were performed during a mean follow-up of 38.9 months. Data included heart rate, heart rate variability, QRS duration (QRSd), QTc interval and its dispersion, Tpeak–Tend (Tp–Te) interval and its dispersion, presence of fragmented QRS (fQRS), T wave alternans, atrial arrhythmias, and non-sustained ventricular tachycardia. Implant indication was primary prevention in ten cases (38.5%) and secondary prevention in 16 (61.5%). Overall, 17 subjects (65.3%) received at least one appropriate and effective ICD discharge. fQRS was present in 64.7% of cases with ICD therapy compared with patients without events or controls (p < 0.0001). Tp–e and Tp–e dispersion were significantly prolonged in patients with recurrences (113.5 and 37.2 ms) versus patients without ICD discharge (89.6 and 24.1 ms) or controls (72.4 and 19.3 ms) (p < 0.0001 and p < 0.0001, respectively). On univariate Cox regression analysis QRSd (hazard ratio: 1.19 per ms, p = 0.003), QTc dispersion (hazard ratio: 1.57 per ms, p = 0.002), fQRS (hazard ratio: 3.58 p < 0.0001), Tp–e (hazard ratio: 2.27 per ms, p < 0.0001), and Tp–e dispersion (hazard ratio: 4.15 per ms, p < 0.0001), emerged as strong predictors of outcome. On multivariate Cox analysis fQRS, Tp–e and Tp–e dispersion remained in the model. The presence of fQRS, and both Tp–e and Tp–e dispersion are useful ECG tools in daily clinical practice to identify CHD patients at risk for appropriate ICD therapy.
Literatur
1.
Zurück zum Zitat Silka MJ, Hardy BG, Menashe VD, Morris CD (1998) A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol 32:245-251.congenital heart defects. J Am Coll Cardiol 32:245–251CrossRefPubMed Silka MJ, Hardy BG, Menashe VD, Morris CD (1998) A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol 32:245-251.congenital heart defects. J Am Coll Cardiol 32:245–251CrossRefPubMed
2.
Zurück zum Zitat Nieminen HP, Jokinen EV (2007) Sairanen HI (2007) Causes of late deaths after pediatric cardiac surgery: a population-based study. J Am Coll Cardiol 50:1263–1271CrossRefPubMed Nieminen HP, Jokinen EV (2007) Sairanen HI (2007) Causes of late deaths after pediatric cardiac surgery: a population-based study. J Am Coll Cardiol 50:1263–1271CrossRefPubMed
3.
Zurück zum Zitat Koyak Z, Harris L, de Groot JR et al (2012) Sudden cardiac death in adult congenital heart disease. Circulation 126:1944–1954CrossRefPubMed Koyak Z, Harris L, de Groot JR et al (2012) Sudden cardiac death in adult congenital heart disease. Circulation 126:1944–1954CrossRefPubMed
4.
Zurück zum Zitat Khairy P, Harris L, Landzberg MJ et al (2008) Implantable cardioverter-defibrillators in tetralogy of Fallot. Circulation 117:363–370CrossRefPubMed Khairy P, Harris L, Landzberg MJ et al (2008) Implantable cardioverter-defibrillators in tetralogy of Fallot. Circulation 117:363–370CrossRefPubMed
5.
Zurück zum Zitat Khairy P, Harris L, Landzberg MJ et al (2008) Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study. Circ Arrhythm Electrophysiol 1:250–257CrossRefPubMed Khairy P, Harris L, Landzberg MJ et al (2008) Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study. Circ Arrhythm Electrophysiol 1:250–257CrossRefPubMed
6.
Zurück zum Zitat Koyak Z, de Groot JR, Van Gelder IC et al (2012) Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks? Circ Arrhythm Electrophysiol 5:101–110CrossRefPubMed Koyak Z, de Groot JR, Van Gelder IC et al (2012) Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks? Circ Arrhythm Electrophysiol 5:101–110CrossRefPubMed
7.
Zurück zum Zitat De Maso DR, Lauretti A, Spieth L et al (2004) Psychosocial factors and quality of life in children and adolescents with implantable cardioverter-defibrillators. Am J Cardiol 93:582–587CrossRef De Maso DR, Lauretti A, Spieth L et al (2004) Psychosocial factors and quality of life in children and adolescents with implantable cardioverter-defibrillators. Am J Cardiol 93:582–587CrossRef
8.
Zurück zum Zitat Czosek RJ, Bonney WJ, Cassedy A et al (2012) Impact of cardiac devices on the quality of life in pediatric patients. Circ Arrhythm Electrophysiol 5:1064–1072CrossRefPubMed Czosek RJ, Bonney WJ, Cassedy A et al (2012) Impact of cardiac devices on the quality of life in pediatric patients. Circ Arrhythm Electrophysiol 5:1064–1072CrossRefPubMed
9.
Zurück zum Zitat Gatzoulis MA, Till JA, Redington AN (1997) Depolarization-repolarization inhomogeneity after repair of tetralogy of Fallot. Circulation 95:401–404CrossRefPubMed Gatzoulis MA, Till JA, Redington AN (1997) Depolarization-repolarization inhomogeneity after repair of tetralogy of Fallot. Circulation 95:401–404CrossRefPubMed
10.
Zurück zum Zitat Daliento L, Caneve F, Turrini P et al (1995) Clinical significance of high-frequency, low-amplitude electrocardiographic signals and QT dispersion in patients operated on for tetralogy of Fallot. Am J Cardiol 76:408–411CrossRefPubMed Daliento L, Caneve F, Turrini P et al (1995) Clinical significance of high-frequency, low-amplitude electrocardiographic signals and QT dispersion in patients operated on for tetralogy of Fallot. Am J Cardiol 76:408–411CrossRefPubMed
11.
Zurück zum Zitat Daliento L, Rizzoli G, Menti L et al (1999) Accuracy of electrocardiographic and echocardiographic indices in predicting life threatening ventricular arrhythmias in patients operated for tetralogy of Fallot. Heart 81:650–655CrossRefPubMedPubMedCentral Daliento L, Rizzoli G, Menti L et al (1999) Accuracy of electrocardiographic and echocardiographic indices in predicting life threatening ventricular arrhythmias in patients operated for tetralogy of Fallot. Heart 81:650–655CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Sun ZH, Happonen JM, Bennhagen R et al (2004) Increased QT dispersion and loss of sinus rhythm as risk factors for late sudden death after Mustard or Senning procedures for transposition of the great arteries. Am J Cardiol 94:138–141CrossRefPubMed Sun ZH, Happonen JM, Bennhagen R et al (2004) Increased QT dispersion and loss of sinus rhythm as risk factors for late sudden death after Mustard or Senning procedures for transposition of the great arteries. Am J Cardiol 94:138–141CrossRefPubMed
13.
Zurück zum Zitat Bokma JP, Winter MM, Vehmeijer JT et al (2016) QRS fragmentation is superior to QRS duration in predicting mortality in adults with tetralogy of Fallot. Heart. doi:10.1136/heartjnl-2016-310068 Bokma JP, Winter MM, Vehmeijer JT et al (2016) QRS fragmentation is superior to QRS duration in predicting mortality in adults with tetralogy of Fallot. Heart. doi:10.​1136/​heartjnl-2016-310068
14.
Zurück zum Zitat Zipes DP, Camm AJ, Borggrefe M et al (2006) ACC/AHA/ESC guidelines for management of patients with ventricular arrhythmias and the prevention of sudden death. J Am Coll Cardiol 48:247–346CrossRef Zipes DP, Camm AJ, Borggrefe M et al (2006) ACC/AHA/ESC guidelines for management of patients with ventricular arrhythmias and the prevention of sudden death. J Am Coll Cardiol 48:247–346CrossRef
15.
Zurück zum Zitat Epstein AE, Di Marco JP, Ellenbogen KA (2013) 2012 ACCF/AHA/HRS focus update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. J Am Coll Cardiol 61:6–75CrossRef Epstein AE, Di Marco JP, Ellenbogen KA (2013) 2012 ACCF/AHA/HRS focus update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. J Am Coll Cardiol 61:6–75CrossRef
16.
Zurück zum Zitat Khairy P, Van Hare GF, Balaji S (2014) PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease. Heart Rhythm 11:102–165CrossRef Khairy P, Van Hare GF, Balaji S (2014) PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease. Heart Rhythm 11:102–165CrossRef
17.
Zurück zum Zitat Aykan HH, Karagoz T, Gulgun M et al (2016) Midterm results of implantable cardioverter defibrillators in children and young adults from a single center in Turkey. PACE 39:1225–1239CrossRefPubMed Aykan HH, Karagoz T, Gulgun M et al (2016) Midterm results of implantable cardioverter defibrillators in children and young adults from a single center in Turkey. PACE 39:1225–1239CrossRefPubMed
18.
Zurück zum Zitat Berul CI, Van Hare GF, Kertesz NJ et al (2012) Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol 51:1685–1691CrossRef Berul CI, Van Hare GF, Kertesz NJ et al (2012) Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol 51:1685–1691CrossRef
19.
Zurück zum Zitat Von Berge NH, Atkins DL, Dick M II et al (2011) Multicenter study of the effectiveness of implantable cardioverter defibrillators in children and young adults with heart disease. Pediatr Cardiol 32:399–405CrossRef Von Berge NH, Atkins DL, Dick M II et al (2011) Multicenter study of the effectiveness of implantable cardioverter defibrillators in children and young adults with heart disease. Pediatr Cardiol 32:399–405CrossRef
20.
Zurück zum Zitat Kamp AN, Von Bergen NH, Henrikson CA et al (2013) Implanted defibrillators in young hypertrophic cardiomyopathy patients: a multicenter study. Pediatr Cardiol 34:1620–1627CrossRefPubMed Kamp AN, Von Bergen NH, Henrikson CA et al (2013) Implanted defibrillators in young hypertrophic cardiomyopathy patients: a multicenter study. Pediatr Cardiol 34:1620–1627CrossRefPubMed
21.
Zurück zum Zitat Zhang L, Mmagu O, Liu L et al (2014) Hypertrophic cardiomyopathy: can the noninvasive diagnostic testing identify high risk patients? World J Cardiol 6:764–770CrossRefPubMedPubMedCentral Zhang L, Mmagu O, Liu L et al (2014) Hypertrophic cardiomyopathy: can the noninvasive diagnostic testing identify high risk patients? World J Cardiol 6:764–770CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Peters S, Trümmel M, Koehler B (2008) QRS fragmentation in standard ECG as a diagnostic marker of arrhythmogenic right ventricular dysplasia cardiomyopathy. Heart Rhythm 5:1417–1421CrossRefPubMed Peters S, Trümmel M, Koehler B (2008) QRS fragmentation in standard ECG as a diagnostic marker of arrhythmogenic right ventricular dysplasia cardiomyopathy. Heart Rhythm 5:1417–1421CrossRefPubMed
23.
Zurück zum Zitat Das MK, Michael MA, Suradi H et al (2009) Usefulness of fragmented QRS on a 12-lead electrocardiogram in acute coronary syndrome for predicting mortality. Am J Cardiol 104:1631–1637CrossRefPubMed Das MK, Michael MA, Suradi H et al (2009) Usefulness of fragmented QRS on a 12-lead electrocardiogram in acute coronary syndrome for predicting mortality. Am J Cardiol 104:1631–1637CrossRefPubMed
24.
Zurück zum Zitat Ning XH, Tang M, Chen KP et al (2012) The prognostic significance of fragmented QRS in patients with left ventricular noncompaction cardiomyopathy. Can J Cardiol 28:508–514CrossRefPubMed Ning XH, Tang M, Chen KP et al (2012) The prognostic significance of fragmented QRS in patients with left ventricular noncompaction cardiomyopathy. Can J Cardiol 28:508–514CrossRefPubMed
25.
Zurück zum Zitat Park SJ, On YK, Kim JS et al (2012) Relation of fragmented QRS complex to right ventricular fibrosis detected by late gadolinium enhancement cardiac magnetic resonance in adults with repaired tetralogy of Fallot. Am J Cardiol 109:110–115CrossRefPubMed Park SJ, On YK, Kim JS et al (2012) Relation of fragmented QRS complex to right ventricular fibrosis detected by late gadolinium enhancement cardiac magnetic resonance in adults with repaired tetralogy of Fallot. Am J Cardiol 109:110–115CrossRefPubMed
26.
Zurück zum Zitat Egidy Assenza G, Valente AM, Geva T et al (2013) QRS duration and QRS fractionation on surface electrocardiogram are markers of right ventricular dysfunction and atrialization in patients with Ebstein anomaly. Eur Heart J 34:191–200CrossRefPubMed Egidy Assenza G, Valente AM, Geva T et al (2013) QRS duration and QRS fractionation on surface electrocardiogram are markers of right ventricular dysfunction and atrialization in patients with Ebstein anomaly. Eur Heart J 34:191–200CrossRefPubMed
27.
Zurück zum Zitat Apiyasawat S, Sahasthas D, Ngarmukos T et al (2014) Fragmented QRS as a predictor of appropriate implantable cardioverter-defibrillator therapy. Indian Pacing Electrophysiol J 14:4–11CrossRefPubMedPubMedCentral Apiyasawat S, Sahasthas D, Ngarmukos T et al (2014) Fragmented QRS as a predictor of appropriate implantable cardioverter-defibrillator therapy. Indian Pacing Electrophysiol J 14:4–11CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Park SJ, Chung S, On YK et al (2013) Fragmented QRS complex in adult patients with Ebstein anomaly and its association with arrhythmic risk and the severity of the anomaly. Cir Arrhythm Electrophysiol 6:1148–1155CrossRef Park SJ, Chung S, On YK et al (2013) Fragmented QRS complex in adult patients with Ebstein anomaly and its association with arrhythmic risk and the severity of the anomaly. Cir Arrhythm Electrophysiol 6:1148–1155CrossRef
29.
Zurück zum Zitat Vogels RJ, Teuwen CP, Ramdjan TTTK et al (2017) Usefulness of fragmented QRS complexes in patients with congenital heart disease to predict ventricular tachyarrythmias. Am J Cardiol 119:126–131CrossRefPubMed Vogels RJ, Teuwen CP, Ramdjan TTTK et al (2017) Usefulness of fragmented QRS complexes in patients with congenital heart disease to predict ventricular tachyarrythmias. Am J Cardiol 119:126–131CrossRefPubMed
30.
Zurück zum Zitat Topilski I, Rogowski O, Rosso R et al (2007) The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias. J Am Coll Cardiol 49:320–328CrossRefPubMed Topilski I, Rogowski O, Rosso R et al (2007) The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias. J Am Coll Cardiol 49:320–328CrossRefPubMed
31.
Zurück zum Zitat Graff C, Andersen MP, Xue JQ et al (2009) Identifying drug-induced repolarization abnormalities from distinct ECG patterns in congenital long QT syndrome: a study of sotalol effects on T-wave morphology. Drug Saf 32:599–611CrossRefPubMed Graff C, Andersen MP, Xue JQ et al (2009) Identifying drug-induced repolarization abnormalities from distinct ECG patterns in congenital long QT syndrome: a study of sotalol effects on T-wave morphology. Drug Saf 32:599–611CrossRefPubMed
32.
Zurück zum Zitat Shah RR (2005) Drug-induced QT dispersion: does it predict the risk of torsade de pointes? J Electrocardiol 38:10–18CrossRefPubMed Shah RR (2005) Drug-induced QT dispersion: does it predict the risk of torsade de pointes? J Electrocardiol 38:10–18CrossRefPubMed
33.
Zurück zum Zitat Sarubbi B, Pacileo G, Ducceschi V et al (1999) Arrhythmogenic substrate in young patients with repaired tetralogy of Fallot: role of an abnormal ventricular repolarization. Int J Cardiol 72:73–82CrossRefPubMed Sarubbi B, Pacileo G, Ducceschi V et al (1999) Arrhythmogenic substrate in young patients with repaired tetralogy of Fallot: role of an abnormal ventricular repolarization. Int J Cardiol 72:73–82CrossRefPubMed
34.
Zurück zum Zitat Özkan S, Akay T, Gültekin B et al (2005) Ventricular arrhythmia and tetralogy of Fallot repair with transannular patch. Anadolu Kardiyol Derg 5:297–301PubMed Özkan S, Akay T, Gültekin B et al (2005) Ventricular arrhythmia and tetralogy of Fallot repair with transannular patch. Anadolu Kardiyol Derg 5:297–301PubMed
35.
Zurück zum Zitat Berul CI, Hill SL, Geggel RL et al (1997) Electrocardiographic markers of late sudden death risk in postoperative tetralogy of Fallot children. J Cardiovasc Electrophysiol 8:1349–1356CrossRefPubMed Berul CI, Hill SL, Geggel RL et al (1997) Electrocardiographic markers of late sudden death risk in postoperative tetralogy of Fallot children. J Cardiovasc Electrophysiol 8:1349–1356CrossRefPubMed
36.
Zurück zum Zitat Huh J, Noh CI, Choi JY et al (2001) Sustained ventricular tachycardia in children after repair of congenital heart disease. J Korean Med Sci 16:25–30CrossRefPubMedPubMedCentral Huh J, Noh CI, Choi JY et al (2001) Sustained ventricular tachycardia in children after repair of congenital heart disease. J Korean Med Sci 16:25–30CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Ibanez A, Ferrero JM (2006) The ECG T-wave duration as an index of dispersion of ventricular repolarization: insights from simulations. Comput Cardiol 33:793–796 Ibanez A, Ferrero JM (2006) The ECG T-wave duration as an index of dispersion of ventricular repolarization: insights from simulations. Comput Cardiol 33:793–796
38.
Zurück zum Zitat Yan GX, Antzelevitch C (1998) Cellular basis for the normal T wave and the electrocardiographic manifestations of the long QT syndrome. Circulation 98:1928–1936CrossRefPubMed Yan GX, Antzelevitch C (1998) Cellular basis for the normal T wave and the electrocardiographic manifestations of the long QT syndrome. Circulation 98:1928–1936CrossRefPubMed
39.
Zurück zum Zitat Xia Y, Liang Y, Kongstad O et al (2005) In vivo validation of the coincidence of the peak and end of the T wave with full repolarization of the epicardium and endocardium in swine. Heart Rhythm 2:162–169CrossRefPubMed Xia Y, Liang Y, Kongstad O et al (2005) In vivo validation of the coincidence of the peak and end of the T wave with full repolarization of the epicardium and endocardium in swine. Heart Rhythm 2:162–169CrossRefPubMed
40.
Zurück zum Zitat Xia Y, Liang Y, Kongstad O (2005) Tpeak-Tend as an index of global dispersion of ventricular repolarization: evaluations using monophasic action potential mapping of the epi- and endocardium in swine. J Interv Card Electrophysiol 14:79–87CrossRefPubMed Xia Y, Liang Y, Kongstad O (2005) Tpeak-Tend as an index of global dispersion of ventricular repolarization: evaluations using monophasic action potential mapping of the epi- and endocardium in swine. J Interv Card Electrophysiol 14:79–87CrossRefPubMed
41.
Zurück zum Zitat Shimizu M, Ino H, Okeie K et al (2002) T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion. Clin Cardiol 25:335–339CrossRefPubMed Shimizu M, Ino H, Okeie K et al (2002) T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion. Clin Cardiol 25:335–339CrossRefPubMed
42.
Zurück zum Zitat Hevia JC, Antzelevitch C, Barzaga FT et al (2006) Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada syndrome. J Am Coll Cardiol 47:1828–1834CrossRefPubMedCentral Hevia JC, Antzelevitch C, Barzaga FT et al (2006) Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada syndrome. J Am Coll Cardiol 47:1828–1834CrossRefPubMedCentral
43.
Zurück zum Zitat Morin DP, Saad MN, Shams OF et al (2011) Relationships between the T-peak to T-end interval, ventricular tachyarrhythmia, and death in left ventricular systolic dysfunction. Europace 14:1172–1279CrossRef Morin DP, Saad MN, Shams OF et al (2011) Relationships between the T-peak to T-end interval, ventricular tachyarrhythmia, and death in left ventricular systolic dysfunction. Europace 14:1172–1279CrossRef
44.
Zurück zum Zitat Lellouche N, De Diego C, Akopyan G et al (2007) Changes and predictive value of dispersion of repolarization parameters for appropriate therapy in patients with biventricular implantable cardioverter-defibrillators. Heart Rhythm 4:1274–1283CrossRefPubMed Lellouche N, De Diego C, Akopyan G et al (2007) Changes and predictive value of dispersion of repolarization parameters for appropriate therapy in patients with biventricular implantable cardioverter-defibrillators. Heart Rhythm 4:1274–1283CrossRefPubMed
Metadaten
Titel
Electrocardiographic Markers of Appropriate Implantable Cardioverter-Defibrillator Therapy in Young People with Congenital Heart Diseases
verfasst von
Dunia Bárbara Benítez Ramos
Michel Cabrera Ortega
Jesús Castro Hevia
Margarita Dorantes Sánchez
Ailema Amelia Alemán Fernández
Osmin Castañeda Chirino
Marlenis Cruz Cardentey
Frank Martínez López
Roylan Falcón Rodríguez
Publikationsdatum
04.09.2017
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 8/2017
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-017-1711-9

Weitere Artikel der Ausgabe 8/2017

Pediatric Cardiology 8/2017 Zur Ausgabe

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.